Literature DB >> 23982393

Extraskeletal Ewing sarcoma in children and adolescents: impact of narrow but negative surgical margin.

Sajid S Qureshi1, Siddharth Laskar, Seema Kembhavi, Sanjay Talole, Girish Chinnaswamy, Tushar Vora, Mukta Ramadwar, Saral Desai, Nehal Khanna, Mary Ann Muckaden, Purna Kurkure.   

Abstract

PURPOSE: The aim of the study was to determine the impact of negative but close resection margins on local recurrence in children with extraskeletal Ewing sarcoma (EES).
METHOD: We reviewed records of 32 patients with EES treated between March 2005 and March 2013. All patients except one underwent surgical excision either upfront or after induction chemotherapy. Patients with viable tumor and negative surgical margins, which were categorized as less than or greater than 1 cm, were selected. Local control and survival analysis were performed for patients in both the groups.
RESULTS: The 5-year event-free and overall survival rates of entire cohort is 68 and 77 %, respectively. Surgical margins were negative in 23/26 (90.3 %) patients. There were no local recurrences in any of the patients with margins of less than 1 cm. Only one patient with a margin greater than 1 cm had a local recurrence along with distant metastases. A tumor-free margin of more than 1 cm did not affect overall or event-free survival (p = NS).
CONCLUSION: Optimal local control is feasible in children with EES regardless of the quantitative extent of negative margins. Achieving a three-dimensional tumor-free margin should be the goal of surgical resection.

Entities:  

Mesh:

Year:  2013        PMID: 23982393     DOI: 10.1007/s00383-013-3409-2

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  17 in total

1.  Comparison of soft tissue Ewing's sarcoma and peripheral neuroectodermal tumor.

Authors:  K A Siebenrock; A G Nascimento; M G Rock
Journal:  Clin Orthop Relat Res       Date:  1996-08       Impact factor: 4.176

2.  Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.

Authors:  W Shannon Orr; W Shannon Orr; Jason W Denbo; Catherine A Billups; Jianrong Wu; Fariba Navid; Bhaskar N Rao; Andrew M Davidoff; Matthew J Krasin
Journal:  Ann Surg Oncol       Date:  2012-06-28       Impact factor: 5.344

3.  Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.

Authors:  P Picci; T Böhling; G Bacci; S Ferrari; L Sangiorgi; M Mercuri; P Ruggieri; M Manfrini; A Ferraro; R Casadei; M S Benassi; A F Mancini; P Rosito; A Cazzola; E Barbieri; A Tienghi; A Brach del Prever; A Comandone; P Bacchini; F Bertoni
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

4.  Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology.

Authors:  Marie-Pierre Castex; Hervé Rubie; Michael C G Stevens; Carlota Calvo Escribano; Jérôme Sales de Gauzy; Anne Gomez-Brouchet; Annie Rey; Olivier Delattre; Odile Oberlin
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

5.  Extraskeletal Ewing's sarcoma family of tumours in adults: analysis of 57 patients from a single institution.

Authors:  A El Weshi; A Allam; D Ajarim; F Al Dayel; R Pant; S Bazarbashi; M Memon
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-06       Impact factor: 4.126

6.  Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.

Authors:  Deniz Tural; Nil Molinas Mandel; Sergulen Dervisoglu; Fazilet Oner Dincbas; Sedat Koca; Didem Colpan Oksuz; Fatih Kantarci; Hande Turna; Fatih Selcukbiricik; Murat Hiz
Journal:  Jpn J Clin Oncol       Date:  2012-03-12       Impact factor: 3.019

7.  Prognostic factors in primary nonmetastatic Ewing sarcoma of the rib in children and young adults.

Authors:  Sajid S Qureshi; Seema Kembhavi; Tushar Vora; Mukta Ramadwar; Siddharth Laskar; Sanjay Talole; Purna Kurkure
Journal:  J Pediatr Surg       Date:  2013-04       Impact factor: 2.545

8.  Extraskeletal Ewing's sarcoma: results of combined modality treatment.

Authors:  T J Kinsella; T J Triche; P S Dickman; J Costa; J E Tepper; D Glaubiger
Journal:  J Clin Oncol       Date:  1983-08       Impact factor: 44.544

9.  Extraosseous Ewing's sarcoma. A study of 42 cases.

Authors:  N P Rud; H M Reiman; D J Pritchard; F J Frassica; W A Smithson
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860

10.  A system for the surgical staging of musculoskeletal sarcoma. 1980.

Authors:  William F Enneking; Suzanne S Spanier; Mark A Goodman
Journal:  Clin Orthop Relat Res       Date:  2003-10       Impact factor: 4.176

View more
  5 in total

1.  Are Skin Fiducials Comparable to Bone Fiducials for Registration When Planning Navigation-assisted Musculoskeletal Tumor Resections in a Cadaveric Simulated Tumor Model?

Authors:  Rodolfo Zamora; Stephanie E Punt; Claudia Christman-Skieller; Cengiz Yildirim; John C Shapton; Ernest U Conrad
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

2.  Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.

Authors:  C A Maroun; I Khalifeh; A Tfayli; R V Moukarbel
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

Review 3.  Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management.

Authors:  George Galyfos; Georgios A Karantzikos; Nikolaos Kavouras; Argiri Sianou; Konstantinos Palogos; Konstantinos Filis
Journal:  Indian J Surg       Date:  2015-11-13       Impact factor: 0.656

Review 4.  Primary Ewing's sarcoma/primitive neuroectodermal tumor of the ileum: case report of a 16-year-old Chinese female and literature review.

Authors:  Teng Li; Fang Zhang; Yarui Cao; Shoubin Ning; Yongmin Bi; Weicheng Xue; Li Ren
Journal:  Diagn Pathol       Date:  2017-05-04       Impact factor: 2.644

5.  Extraskeletal Ewing's sarcoma: outcomes and CT features of endoceliac lesions.

Authors:  Zeyang Chen; Yang Jiao; Zining Liu; Jiejin Yang; Jiali Sun; Pengyuan Wang
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.